CRISPR in Parasitology: Not Exactly Cut and Dried!


Journal

Trends in parasitology
ISSN: 1471-5007
Titre abrégé: Trends Parasitol
Pays: England
ID NLM: 100966034

Informations de publication

Date de publication:
06 2019
Historique:
received: 08 02 2019
revised: 13 03 2019
accepted: 14 03 2019
pubmed: 23 4 2019
medline: 28 5 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

CRISPR/Cas9 technology has been developing rapidly in the field of parasitology, allowing for the dissection of molecular processes with unprecedented efficiency. Optimization and implementation of a new technology like CRISPR, especially in nonmodel organisms, requires communication and collaboration throughout the field. Recently, a 'CRISPR in Parasitology' symposium was held at the Institut Pasteur Paris, bringing together scientists studying Leishmania, Plasmodium, Trypanosoma, and Anopheles. Here we share technological advances and challenges in using CRISPR/Cas9 in the parasite and vector systems that were discussed. As CRISPR/Cas9 continues to be applied to diverse parasite systems, the community should now focus on improvement and standardization of the technique as well as expanding the CRISPR toolkit to include Cas9 alternatives/derivatives for more advanced applications like genome-wide functional screens.

Identifiants

pubmed: 31006600
pii: S1471-4922(19)30055-8
doi: 10.1016/j.pt.2019.03.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-422

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Jessica M Bryant (JM)

Biology of Host-Parasite Interactions Unit, Institut Pasteur, 75015 Paris, France; INSERM, Unit U1201, Paris, France; CNRS, ERL 9195, Paris, France. Electronic address: jessica.bryant@pasteur.fr.

Sebastian Baumgarten (S)

Biology of Host-Parasite Interactions Unit, Institut Pasteur, 75015 Paris, France; INSERM, Unit U1201, Paris, France; CNRS, ERL 9195, Paris, France.

Lucy Glover (L)

Trypanosome Molecular Biology Group, Institut Pasteur, 75015 Paris, France.

Sebastian Hutchinson (S)

INSERM, Unit U1201, Paris, France; Trypanosome Cell Biology Unit, Institut Pasteur, 75015 Paris, France.

Najma Rachidi (N)

INSERM, Unit U1201, Paris, France; Molecular Parasitology and Signaling Unit, Institut Pasteur, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH